DE69634446D1 - Selektive alkylierung von cyclodextrinen mit minimaler effektiver basizität - Google Patents

Selektive alkylierung von cyclodextrinen mit minimaler effektiver basizität

Info

Publication number
DE69634446D1
DE69634446D1 DE69634446T DE69634446T DE69634446D1 DE 69634446 D1 DE69634446 D1 DE 69634446D1 DE 69634446 T DE69634446 T DE 69634446T DE 69634446 T DE69634446 T DE 69634446T DE 69634446 D1 DE69634446 D1 DE 69634446D1
Authority
DE
Germany
Prior art keywords
cyclodextrins
cyclodextrin
selective alkylation
minimally effective
hydroxyls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634446T
Other languages
English (en)
Other versions
DE69634446T2 (de
Inventor
Joseph Rockville Pitha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Application granted granted Critical
Publication of DE69634446D1 publication Critical patent/DE69634446D1/de
Publication of DE69634446T2 publication Critical patent/DE69634446T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69634446T 1995-12-19 1996-12-18 Selektive alkylierung von cyclodextrinen mit minimaler effektiver basizität Expired - Lifetime DE69634446T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US575075 1995-12-19
US08/575,075 US5681828A (en) 1995-12-19 1995-12-19 Selective alkylations of cyclodextrins leading to derivatives which have a rigidly extended cavity
PCT/US1996/020029 WO1997022630A1 (en) 1995-12-19 1996-12-18 Selective alkylations of cyclodextrins at the levels of minimal effective basicity

Publications (2)

Publication Number Publication Date
DE69634446D1 true DE69634446D1 (de) 2005-04-14
DE69634446T2 DE69634446T2 (de) 2006-04-13

Family

ID=24298829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634446T Expired - Lifetime DE69634446T2 (de) 1995-12-19 1996-12-18 Selektive alkylierung von cyclodextrinen mit minimaler effektiver basizität

Country Status (10)

Country Link
US (1) US5681828A (de)
EP (1) EP0868438B1 (de)
JP (3) JP3476201B2 (de)
AT (1) ATE290550T1 (de)
AU (1) AU1565997A (de)
CA (1) CA2240413C (de)
DE (1) DE69634446T2 (de)
ES (1) ES2238703T3 (de)
WO (1) WO1997022630A1 (de)
ZA (1) ZA9610711B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001821A (en) * 1995-12-19 1999-12-14 Pitha; Josef Dioxane-substituted cyclodextrin macromolecules and inclusion complexes
DE19930553A1 (de) * 1999-07-02 2001-01-11 Wacker Chemie Gmbh Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten
WO2004069187A2 (en) * 2003-02-03 2004-08-19 Shire Laboratories, Inc. Drug formulation and delivery using crystalline methylated cyclodextrins
KR100785913B1 (ko) * 2006-11-29 2007-12-17 한국과학기술연구원 경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법
JP2009040873A (ja) * 2007-08-08 2009-02-26 Lintec Corp 部分アシル化シクロデキストリンの製造方法および部分アシル化ロタキサンの製造方法
EP2923702A1 (de) * 2014-03-28 2015-09-30 Universite De Liege Zusammensetzung von Cyclodextrin mit Budesonidderivaten zur Behandlung und Vorbeugung von entzündlichen Lungenerkrankungen
CN112646058A (zh) * 2019-10-11 2021-04-13 南京大学 一种两亲性多孔环糊精聚合物
CN112661874B (zh) * 2020-12-30 2022-01-07 曲阜市天利药用辅料有限公司 6-位羟丙基取代β-环糊精功能药辅助剂及其制备方法
US20220332924A1 (en) * 2021-04-09 2022-10-20 Qatar Foundation For Education, Science And Community Development Cyclodextrin-derived polymer nanoparticles for adsorption and synthesis thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
JPS6259601A (ja) * 1985-09-09 1987-03-16 Nippon Shokuhin Kako Kk エ−テル化サイクロデキストリンの製造方法
DE4333598A1 (de) * 1993-10-01 1995-04-06 Consortium Elektrochem Ind Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten, nach dem Verfahren herstellbare methylierte Cyclodextrin-Derivate und die Verwendung der Produkte

Also Published As

Publication number Publication date
CA2240413C (en) 2008-09-23
ATE290550T1 (de) 2005-03-15
DE69634446T2 (de) 2006-04-13
US5681828A (en) 1997-10-28
EP0868438A1 (de) 1998-10-07
JP2003201303A (ja) 2003-07-18
JP4056437B2 (ja) 2008-03-05
ZA9610711B (en) 1997-06-27
AU1565997A (en) 1997-07-14
WO1997022630A1 (en) 1997-06-26
JP3476201B2 (ja) 2003-12-10
CA2240413A1 (en) 1997-06-26
JP2003342302A (ja) 2003-12-03
ES2238703T3 (es) 2005-09-01
JP2000502381A (ja) 2000-02-29
EP0868438B1 (de) 2005-03-09
EP0868438A4 (de) 2001-02-07

Similar Documents

Publication Publication Date Title
DE69634446D1 (de) Selektive alkylierung von cyclodextrinen mit minimaler effektiver basizität
FI954360A0 (fi) Kasvaimen hyljintäantigeenin esiastetta koodittava nukseiinihappo
NO902954D0 (no) Fremgangsmaate for fremstilling av substituerte kinazolinoner som angitensin ii-antagonister.
ATE126509T1 (de) Disäuren von diarylstyrylchinolin.
DE69919700D1 (de) Überbrückte indenopyrrolocarbazole
NO903449L (no) Fremgangsmaate for aa behandle underjordiske formasjoner.
GR1001407B (el) Υποκατεστημένες ισοξαζολιδίνες και ισοξαζολίνες.
ES8801168A1 (es) Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
ATE161272T1 (de) Sulfoalkylgruppenhaltige alkylhydroxyalkylcelluloseether
SE8401408D0 (sv) Lignosulfonatderivat
ES2186903T3 (es) Procedimiento de fabricacion de una suspension de celulosa.
NO149469C (no) Pumpbar, tiksotropisk, vandig sementoppslemning og vandig blanding for fremstilling av oppslemningen samt anvendelse av oppslemningen
YU46561B (sh) Postupak za stabilizaciju vodenog rastvora ranitidina
ES2097103T1 (es) Metodo de producir almidon cationico.
AR248126A1 (es) Nuevos derivados sustituidos de bicicloheptanodiona, procedimiento para obtenerlos y composiciones herbicidas que los contienen.
FI901610A0 (fi) Foerfarande foer malning av portlandcementklinker foer framstaellning av gipsfria portlandcementer.
IT1261694B (it) Composizione e procedimento per prevenire la evaporazione per malte dicemento e calcestruzzo.
MXPA03008248A (es) Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina.
PT1192284E (pt) Curtimenta de couro
IT1069863B (it) Sali di resine di idrocarburi stirolo-indenici,particolarmente utili come fluidificanti per impasti e leganti minerali,e procedimento per la loro preparazione
DK595383A (da) C-3''-alkylerede oleandomycin-derivater og 10- og 4''-epi-derivater deraf samt fremgangsmaade til fremstilling deraf
BR9909756A (pt) Processo para a preparação de um composto
BR9912885A (pt) Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".

Legal Events

Date Code Title Description
8364 No opposition during term of opposition